Overview

BioMarin Pharmaceutical Inc. (BioMarin) is a biotechnology company, which is engaged in developing and commercializing therapies that address the root cause of genetic conditions. BioMarin's...

Open

$65.18

Prior close

$65.08

Today's high

$65.25

Today's low

$63.84

52 Week high

$70.98

52 Week low

$49.26

News

MarketBeat • 18 hours ago • BMRN

BioMarin Targets Amicus Synergies as VOXZOGO Nears $1B Milestone

Zacks Investment Research • 2 days ago • BMRN

BioMarin Stops Voxzogo Development for Noonan Syndrome

Seeking Alpha • 4 days ago • BMRN

BioMarin Pharmaceutical Inc. (BMRN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

PRNewsWire • 4 days ago • BMRN

BioMarin Announces Appointment of Robert Plenge, M.D., Ph.D., Chief Research Officer of Bristol Myers Squibb, to Board of Directors

Seeking Alpha • 8 days ago • BMRN

BioMarin Pharmaceutical Inc. (BMRN) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript